KIRBY KLEBER: Open Payments
NPI 1841606951 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 35 payments from 15 companies in 2025. Trend: 2023 $1,158 · 2024 $773 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $147 |
| Lilly USA, LLC | 4 | $70 |
| Novo Nordisk Inc | 3 | $55 |
| PFIZER INC. | 3 | $48 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Abbott Laboratories | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $18 |
Products named: VRAYLAR, JARDIANCE, PROCLAIM, QULIPTA, MOUNJARO, TRELEGY ELLIPTA, Veozah, ELIQUIS.
Industry payments across IN — which companies pay providers there.
